Last reviewed · How we verify

NCT03445494

Shoulder Abduction Brace Against Normal Sling After Arthroscopical Rotator Cuff Suture.

Completed NA Last updated 7 September 2023
What this trial tests

NA trial testing Brace in Supraspinatus Injury in 108 participants. Completed in 11 July 2023.

Timeline
10 January 2018
Primary endpoint
11 July 2023
11 July 2023

Quick facts

Lead sponsorChristian Candrian
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment108
Start date10 January 2018
Primary completion11 July 2023
Estimated completion11 July 2023
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Christian Candrian — full company profile →

Who can join

Adults 18 to 72, any sex, with Supraspinatus Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The patient undergoes arthroscopic surgery to treat rotator cuff injury. At the end of the surgery, the patient will be randomized into group A (brace) or group B (normal sling). Both groups will be also treated according to standard of care with physiotherapy and progressive introduction of movements.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Brace

Trials testing the same drug.

Other Christian Candrian trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03445494.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing